Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 41

Trial Status

Recruiting1
Other2

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Clinical Trials (3)

NCT05999656Not ApplicableUnknown
Human Cord Blood Mononuclear Cells in the Treatment of Refractory Diabetic Foot
EfficacyHuman Cord Blood-derived Mononuclear CellsLocal Injection+2 more
StudychairStart date: 2023-05-28
NCT05461820Phase 4Recruiting
Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
Drug WithdrawalGraves DiseaseRelapse+1 more
StudychairStart date: 2018-05-01

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xuqin Zheng

The First Affiliated Hospital with Nanjing Medical University

Very Similar
2 trials

Shared therapeutic areas:

Drug WithdrawalEfficacyGraves Disease+6 more

Worked with same sponsors:

Shandong Qilu Stem Cells Engineering Co., Ltd.The First Affiliated Hospital with Nanjing Medical University
Collaborated on 2 trials
Similarity Score98%

Manuel Gonzalez, PHD

University of Guadalajara

Related
11 trials

Shared therapeutic areas:

Prediabetic StateImpaired Fasting Glucose
Similarity Score5%

Zhaoping Li, MD, PhD

University of California, Los Angeles

Related
17 trials

Shared therapeutic areas:

Prediabetic State
Similarity Score2%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Therapeutics

Worked with same sponsors:

Fujian Medical University Union HospitalNanjing Medical University+1 more
Similarity Score2%

Ali MA Ismail, lecturer

Cairo University

Related
27 trials

Shared therapeutic areas:

Prediabetic State
Similarity Score2%

Jill Crandall, MD

Albert Einstein College of Medicine

Related
4 trials

Shared therapeutic areas:

Prediabetic State
Similarity Score2%

Timothy S. Church, MD, MPH, PhD

Pennington Biomedical Research Center

Related
6 trials

Shared therapeutic areas:

Prediabetic State
Similarity Score2%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Relapse

Worked with same sponsors:

Fujian Medical University Union HospitalThe First Affiliated Hospital of Zhengzhou University
Similarity Score2%

Charles Conway, MD

Washington University School of Medicine

Related
6 trials

Shared therapeutic areas:

Therapeutics
Similarity Score2%

Sang Yeoup Lee, MD, PhD

Pusan National University Yangsan Hospital

Related
17 trials

Shared therapeutic areas:

Impaired Fasting Glucose
Similarity Score2%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05999656Not ApplicableStudyChair

Human Cord Blood Mononuclear Cells in the Treatment of Refractory Diabetic Foot

EfficacyHuman Cord Blood-derived Mononuclear CellsLocal Injection+2 more
Unknown
NCT05461820Phase 4StudyChair

Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease

Drug WithdrawalGraves DiseaseRelapse+1 more
Recruiting
NCT07854002PrincipalInvestigator

Multimodal Risk Factor Graph Mapping, Metabolic Subtyping, and Digital Intelligent Chronic Disease Management for Prediabetes: An Integrated Cohort and Case-Control Clinical Study

Impaired Fasting GlucoseImpaired Glucose Tolerance (Prediabetes)Prediabetes+1 more
Not Yet Recruiting

All 3 trials loaded